171 related articles for article (PubMed ID: 27660942)
1. Universalis Calcinosis in Adult Dermatomyositis: An "Anti-NXP2 Syndrome".
Fodil D; Meyer A; Salah SS; Sibilia J; Attal N; Tafiani-Lefkir S
J Clin Rheumatol; 2016 Oct; 22(7):387-9. PubMed ID: 27660942
[No Abstract] [Full Text] [Related]
2. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
Tansley SL; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Wedderburn LR; McHugh NJ;
Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis.
Rodríguez-Lozano AL; Mata-Aguilera X; Rivas-Larrauri F; Bustamante-Ogando JC; Gutierrez-Hernandez A; Bojalil-Cabildo A; Scheffler-Mendoza S; Yamazaki-Nakashimada M
Int J Rheum Dis; 2024 Jun; 27(6):e15239. PubMed ID: 38923294
[No Abstract] [Full Text] [Related]
4. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.
Fredi M; Bartoli F; Cavazzana I; Ceribelli A; Carabellese N; Tincani A; Satoh M; Franceschini F
Clin Exp Rheumatol; 2017; 35(2):303-308. PubMed ID: 27908312
[TBL] [Abstract][Full Text] [Related]
5. Calcinosis universalis in adult-onset dermatomyositis.
Bernardino V; Rodrigues A; Panarra A; Riso N
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26272968
[No Abstract] [Full Text] [Related]
6. Anti-NXP2 antibody-associated extensive subcutaneous calcinosis in adult-onset myositis.
Goulabchand R; Guilpain P; Cyteval C; Le Quellec A
Rheumatology (Oxford); 2017 Oct; 56(10):1661. PubMed ID: 28605526
[No Abstract] [Full Text] [Related]
7. Pemphigus foliaceus associated with anti-NXP2 autoantibody-positive dermatomyositis.
Fujimoto N; Takayama S; Hamaguchi Y; Fujimoto M; Tanaka T
Acta Derm Venereol; 2014 Jul; 94(4):478-9. PubMed ID: 24217940
[No Abstract] [Full Text] [Related]
8. [Dermatomyositis-specific antibodies].
Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of polymyositis and dermatomyositis.
Targoff IN
Compr Ther; 1990 Apr; 16(4):16-24. PubMed ID: 2185913
[No Abstract] [Full Text] [Related]
10. [Dermatomyositis].
Basset A; Maleville J; Bergoend H; Grosshans E; Heid E; Schubert B; Vetter JM
Bull Soc Fr Dermatol Syphiligr; 1971; 78(2):165-6. PubMed ID: 5128255
[No Abstract] [Full Text] [Related]
11. [Clinical and therapeutic aspects of dermatomyositis in childhood].
Garibaldi LR; Battistini E
Minerva Pediatr; 1978 Nov; 30(22):1793-5. PubMed ID: 723825
[No Abstract] [Full Text] [Related]
12. Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib.
Robert M; Gallay L; Garnier L; Pescarmona R; Hot A
Joint Bone Spine; 2023 Jul; 90(4):105532. PubMed ID: 36706944
[No Abstract] [Full Text] [Related]
13. Cutaneous features of dermatomyositis associated with myositis-specific antibodies.
Daly ML; Gordon PA; Creamer D
Br J Dermatol; 2017 Jun; 176(6):1662-1665. PubMed ID: 27579700
[No Abstract] [Full Text] [Related]
14. Anti-NXP2-Positive Paraneoplastic Dermatomyositis With Histopathologic Changes Confined to the Acrosyringia.
Ramírez-Bellver JL; Macías E; Bernárdez C; López-Robles J; Vegas-Sánchez MD; Díaz-Recuero JL; Quiceno H; Requena L
Am J Dermatopathol; 2017 Jan; 39(1):e3-e7. PubMed ID: 28045754
[TBL] [Abstract][Full Text] [Related]
15. Severe adult dermatomyositis with unusual calcinosis.
Garel B; Barète S; Rigolet A; Le Pelletier F; Benveniste O; Hervier B
Rheumatology (Oxford); 2015 Nov; 54(11):2024. PubMed ID: 26286744
[No Abstract] [Full Text] [Related]
16. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
Çakan M; Karadağ ŞG; Ayaz NA
Turk J Pediatr; 2019; 61(5):771-775. PubMed ID: 32105011
[TBL] [Abstract][Full Text] [Related]
17. [A case of juvenile dermatomyositis with calcinosis universalis--remarkable improvement with aluminum hydroxide therapy].
Aihara Y; Mori M; Ibe M; Kuriyama T; Takahashi Y; Shimizu C; Shike H; Mitsuda T; Yokota S
Ryumachi; 1994 Oct; 34(5):879-84. PubMed ID: 7801200
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to nuclear matrix protein 2/MJ in adult-onset dermatomyositis with severe calcinosis.
Sugiura K; Muro Y; Akiyama M
J Am Acad Dermatol; 2012 Oct; 67(4):e167-8. PubMed ID: 22980285
[No Abstract] [Full Text] [Related]
19. Systemic Calcinosis in NXP2-Dermatomyositis.
Martín D; Curbelo J; Moldenhauer F
J Clin Rheumatol; 2019 Jun; 25(4):e35. PubMed ID: 29319550
[No Abstract] [Full Text] [Related]
20. Anti-TIF1-γ autoantibodies-positive dermatomyositis: where is the malignancy?
Zachou A; Zouvelou V; Papadimas GK; Rentzos M; Papadopoulos C
Rheumatology (Oxford); 2018 Apr; 57(4):756. PubMed ID: 28968891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
